Immediate Impact
4 standout
Citing Papers
Dual blockade immunotherapy targeting PD-1/PD-L1 and CTLA-4 in lung cancer
2024 Standout
Monitoring, prophylaxis, and treatment of infections in patients with MM receiving bispecific antibody therapy: consensus recommendations from an expert panel
2023 Standout
Works of Ana Slaughter being referenced
First phase 3 results from CARTITUDE-4: Cilta-cel versus standard of care (PVd or DPd) in lenalidomide-refractory multiple myeloma.
2023
An Updated Analysis of the Stratus Trial (MM-010): Safety and Efficacy of Pomalidomide Plus Low-Dose Dexamethasone (POM + LoDEX) in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM)
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Ana Slaughter | 35 | 31 | 29 | 19 | 45 | |
| Carolina Lonardi | 20 | 18 | 23 | 13 | 30 | |
| Nitin Patel | 24 | 27 | 39 | 19 | 48 | |
| Raphael Lutz | 36 | 31 | 22 | 11 | 48 | |
| Ariel Grajales‐Cruz | 19 | 17 | 38 | 23 | 51 | |
| Titouan Cazaubiel | 47 | 37 | 31 | 11 | 60 | |
| Florence Rabian | 39 | 12 | 29 | 16 | 70 | |
| Daniela V. Wenge | 36 | 34 | 13 | 11 | 52 | |
| Vladimir Ivanov | 35 | 16 | 13 | 15 | 78 | |
| Marianne Huben | 22 | 17 | 27 | 11 | 54 | |
| Christoph Mann | 38 | 34 | 29 | 10 | 50 |
All Works
Loading papers...